Why the combination of ifosfamide and etoposide as a salvage regimen for previously treated soft tissue sarcomas should not be used Fernando Campos Celso Mello Sarcoma European LatinAmerican Network (SELNET) ecancer.org/en/journal/art…

Press release results - new drug for a rare sarcoma 👉🏼 Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase 3 DeFi Trial in Adult Patients with Progressing Desmoid Tumors | BioSpace ⁦Jon Trent, MD, PhD⁩ ⁦Anthony P Conley⁩ biospace.com/article/releas…

Great discussions on today’s Sarcoma Session from AC Camargo BI BOB Meeting “Next Frontiers to Cure Cancer”. Dr. Tomás Soulé Celso Mello Vinod Ravi, MD Salvatore Provenzano Dorian Y. García-Ortega MD, MSc,PhD, FACS

Just chaired the session on H&N Sarcomas in the Next Frontiers to Cure Cancer BI BOB . No better way to finish the sarcoma agenda than with the great talk by Emanuela Palmerini , and interesting case discussion with my colleagues from AC Camargo.

Rare, often misdiagnosed, accounts for 1% of all adult cancers and 15 to 20% of childhood cancers. In 2022, an estimated 17,000 people will be diagnosed, and over 7,200 people will die, 42% of diagnosed cases. Read more here: healthykcmag.com/fighting-cance… #sarcomaawarenessmonth

Vancouver (such a beautiful city!) is yellow now to receive CTOS 2022! I'm super excited for my first face-to-face CTOS meeting. #CTOS2022 CTOS

CTOS Webinar today discussing Alveolar Soft Part Sarcoma. Great presentations on the evolution of treatment, diagnosis, and current evidence-based management. CTOS

First day at #CTOS was amazing. Had the privilege to bump into my Brazilian sarcoma colleagues! Priscila Barreto Coelho, MD Roberto Pestana, MD Fernando Campos

An award that certainly comes with a lot of responsibility. Thank you very much, CTOS! Global outreach, global impact! #CTOS2023

Yes!

It’s out! This guideline JAMA Oncology #desmoid reflects our multidisciplinary global collaboration, highlights new treatment strategies &importance of quality of life. Thanks Bernd Kasper, Alessandro Gronchi, pts, all. Current Management of Desmoid Tumors: A Review. pubmed.ncbi.nlm.nih.gov/38900421/

🎬 It’s a wrap on two fantastic days of #LMS discussions and science with international colleagues! Thanks to LeioMyoSarcoma for this yearly round table. Thanks to Gladdy Lab and Albiruni Razak and the Toronto group for hosting us! Thanks to all speakers and participants!

Wonderful evening with inspiring sarcoma friends at the LeioMyoSarcoma Roundtable in Toronto this year! Liz Connolly Priya Chudasama Tom Wei-Wu Chen

Fantastic presentations today by Danh Truong, PhD and Inga-Marie Schaefer at ‘Next Frontiers to Cure Cancer’ by BI BOB. Enlightening insights on targeting differentiation errors in sarcomas and restoring cell cycle control in GISTs. #sarcomas # GISTS #accamargo

Together with Dr. Bernd Kasper, we explore the pharmacological characteristics of Nirogacestat, its current role in treating desmoid tumors, and future prospects. #DesmoidTumor #Sarcoma tandfonline.com/doi/full/10.10…

Through the lens of the Brazilian Desmoid Tumor Association, we highlight the crucial role of patient advocacy groups in advancing care for those with rare tumors/cancers in developing countries. Philippos Apolinario Costa, MD lnkd.in/dgh-Pjzf

Patient advocacy plays a vital role in improving care for rare cancers in developing countries. Learn how the Desmoid Tumor Brazilian Association (DTBA) is tackling challenges like access to specialists and medications for patients in Brazil: journals.sagepub.com/doi/epdf/10.11… #RareCancers

Special thanks to Philippos Apolinario Costa, MD and Fernando Campos, one of our Editorial Review Board Members, for shedding light on the critical work of the Desmoid Tumor Brazilian Association in enhancing rare cancer care in Brazil

Discussing the reality of sarcoma patient care in Brazil during the SPAGN Annual Conference - Fernando Campos oncodaily.com/url/275114 #Sarcoma #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer #SPAGN